Increased peritoneal permeability at peritoneal dialysis initiation is a potential cardiovascular risk in patients using biocompatible peritoneal dialysis solution

被引:5
作者
Hamasaki, Yoshifumi [1 ]
Doi, Kent [2 ]
Tanaka, Mototsugu [3 ]
Kume, Haruki [2 ]
Ishibashi, Yoshitaka [4 ]
Enomoto, Yutaka [5 ]
Fujita, Toshiro [6 ]
Homma, Yukio [2 ]
Nangaku, Masaomi [3 ]
Noiri, Eisei [3 ]
机构
[1] Univ Tokyo, 22nd Century Med & Res Ctr, Bunkyo Ku, Tokyo 113, Japan
[2] Tokyo Univ Hosp, Tokyo 113, Japan
[3] Univ Tokyo, Bunkyo Ku, Tokyo 113, Japan
[4] Japanese Red Cross Med Ctr, Tokyo, Japan
[5] Mitsui Mem Hosp, Tokyo 101, Japan
[6] Univ Tokyo, Adv Sci & Technol Res Ctr, Div Clin Epigenet, Tokyo 113, Japan
来源
BMC NEPHROLOGY | 2014年 / 15卷
关键词
Biocompatible peritoneal dialysis solution; Cardiovascular disease; Peritoneal dialysis; Peritoneal equilibration test; Peritoneal permeability; MEMBRANE-TRANSPORT STATUS; TECHNIQUE FAILURE; HIGHER MORTALITY; NEUTRAL-PH; SURVIVAL; FLUID; HYPOALBUMINEMIA;
D O I
10.1186/1471-2369-15-173
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Cardiovascular disease is a frequent cause of death in peritoneal dialysis patients. Biocompatible peritoneal dialysis solutions with neutral pH have been anticipated to reduce cardiovascular disease more than conventional peritoneal dialysis solutions with low pH, but it remains unclear which factors at peritoneal dialysis initiation increase cardiovascular risk in patients using biocompatible peritoneal dialysis solutions. This study was undertaken to investigate which clinical factors at peritoneal dialysis initiation, including peritoneal transport status, are associated with cardiovascular event in patients using biocompatible peritoneal dialysis solution. Methods: This retrospective cohort study of peritoneal dialysis patients using biocompatible solutions with neutral pH assessed relations of clinical parameters at peritoneal dialysis initiation to cardiovascular event during the subsequent five years. Results: Of 102 patients who started peritoneal dialysis, cardiovascular event occurred in 18. Age, history of cardiovascular disease before peritoneal dialysis initiation, hemoglobin, serum albumin, C-reactive protein, peritoneal permeability defined by the ratio of dialysate to plasma creatinine concentration at 4 hr (D/Pcre) in peritoneal equilibration test (PET), number of patients in each PET category defined by D/Pcre, and peritoneal protein clearance significantly differed between patients with and without cardiovascular event. For patients divided according to PET category using Kaplan-Meier method, the group of high average to high peritoneal transporters exhibited significantly high incidence of cardiovascular event and mortality compared with the groups of low and low-average peritoneal transporters (Log rank; p = 0.0003 and 0.005, respectively). A Cox proportional hazards model showed independent association of PET category classification with cardiovascular event. Conclusions: Peritoneal permeability expressed as PET category at peritoneal dialysis initiation is an independent cardiovascular risk factor in peritoneal dialysis patients using biocompatible peritoneal dialysis solution with neutral pH. Greater peritoneal permeability at peritoneal dialysis initiation might reflect subclinical vascular disorders.
引用
收藏
页数:8
相关论文
共 23 条
  • [1] [Anonymous], 2006, Am J Kidney Dis, V48 Suppl 1, pS130
  • [2] Meta-analysis: Peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis
    Brimble, K. Scott
    Walker, Michelle
    Margetts, Peter J.
    Kundhal, Kiran K.
    Rabbatt, Christian G.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (09): : 2591 - 2598
  • [3] The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients
    Cho, Yeoungjee
    Johnson, David W.
    Badve, Sunil V.
    Craig, Jonathan C.
    Strippoli, Giovanni F. M.
    Wiggins, Kathryn J.
    [J]. KIDNEY INTERNATIONAL, 2013, 84 (05) : 969 - 979
  • [4] Churchill DN, 1998, J AM SOC NEPHROL, V9, P1285
  • [5] Cardiovascular and Noncardiovascular Mortality Among Patients Starting Dialysis
    de Jager, Dinanda J.
    Grootendorst, Diana C.
    Jager, Kitty J.
    van Dijk, Paul C.
    Tomas, Lonneke M. J.
    Ansell, David
    Collart, Frederic
    Finne, Patrik
    Heaf, James G.
    De Meester, Johan
    Wetzels, Jack F. M.
    Rosendaal, Frits R.
    Dekker, Friedo W.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (16): : 1782 - 1789
  • [6] Peritoneal albumin leakage: 2 year prospective cardiovascular event occurrence and patient survival analysis
    Elsurer, Rengin
    Afsar, Baris
    Sezer, Siren
    Ozdemir, F. Nurhan
    Haberal, Mehmet
    [J]. NEPHROLOGY, 2009, 14 (08) : 712 - 715
  • [7] An update on peritoneal dialysis solutions
    Garcia-Lopez, Elvia
    Lindholm, Bengt
    Davies, Simon
    [J]. NATURE REVIEWS NEPHROLOGY, 2012, 8 (04) : 224 - 233
  • [8] Low-GDP fluid (Gambrosol trio®) attenuates decline of residual renal function in PD patients: a prospective randomized study
    Haag-Weber, Marianne
    Kraemer, Rosemarie
    Haake, Ruediger
    Islam, Mohamed Shariful
    Prischl, Friedrich
    Haug, Ulrike
    Nabut, Jose L.
    Deppisch, Reinhold
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (07) : 2288 - 2296
  • [9] A high peritoneal large pore fluid flux causes hypoalbuminaemia and is a risk factor for death in peritoneal dialysis patients
    Heaf, JG
    Sarac, S
    Afzal, S
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (10) : 2194 - 2201
  • [10] Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis
    Johnson, David W.
    Hawley, Carmel M.
    McDonald, Stephen P.
    Brown, Fiona G.
    Rosman, Johan B.
    Wiggins, Kathryn J.
    Bannister, Kym M.
    Badve, Sunil V.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (06) : 1973 - 1979